3/26
05:49 am
exel
Exelixis (EXEL) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Exelixis (EXEL) was upgraded by Truist Financial Corporation to "strong-buy".
3/16
12:29 pm
exel
Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion [Yahoo! Finance]
Low
Report
Exelixis (EXEL) Valuation After Earnings Beat FDA Progress And Cabometyx Label Expansion [Yahoo! Finance]
3/16
02:16 am
exel
Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink [Yahoo! Finance]
Low
Report
Exelixis Highlights Zanzalintinib RCC Trials, Sequencing Debate, and December CRC PDUFA at Leerink [Yahoo! Finance]
3/16
01:11 am
exel
Exelixis Highlights CABOMETYX Growth, Zanzalintinib PDUFA and Pipeline Strategy at Barclays Conference [Yahoo! Finance]
Low
Report
Exelixis Highlights CABOMETYX Growth, Zanzalintinib PDUFA and Pipeline Strategy at Barclays Conference [Yahoo! Finance]
3/16
12:23 am
exel
Exelixis Highlights $2.4B 2026 Outlook, Cabometyx Momentum and Zanzalintinib Catalysts at Conference [Yahoo! Finance]
Low
Report
Exelixis Highlights $2.4B 2026 Outlook, Cabometyx Momentum and Zanzalintinib Catalysts at Conference [Yahoo! Finance]
3/12
08:03 pm
exel
Here's Why Exelixis (EXEL) is a Strong Growth Stock [Yahoo! Finance]
Low
Report
Here's Why Exelixis (EXEL) is a Strong Growth Stock [Yahoo! Finance]
3/11
02:14 pm
exel
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
11:57 am
exel
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]
3/10
12:42 pm
exel
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/7
05:30 am
exel
Exelixis (EXEL) was downgraded by Zacks Research from "strong-buy" to "hold".
Medium
Report
Exelixis (EXEL) was downgraded by Zacks Research from "strong-buy" to "hold".
3/4
01:56 am
exel
Exelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Medium
Report
Exelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
11:28 am
exel
Exelixis (EXEL) had its price target lowered by Royal Bank Of Canada from $46.00 to $43.00. They now have a "sector perform" rating on the stock.
Low
Report
Exelixis (EXEL) had its price target lowered by Royal Bank Of Canada from $46.00 to $43.00. They now have a "sector perform" rating on the stock.
3/2
01:00 am
exel
Medium
Report
2/28
07:02 pm
exel
3 Reasons Exelixis Stock Could Deliver Market-Beating Returns Over the Next Decade [Yahoo! Finance]
Medium
Report
3 Reasons Exelixis Stock Could Deliver Market-Beating Returns Over the Next Decade [Yahoo! Finance]
2/24
04:31 pm
exel
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March [Yahoo! Finance]
2/24
04:05 pm
exel
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
Low
Report
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
2/24
10:58 am
exel
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
Low
Report
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
2/22
02:02 am
exel
Low
Report
2/20
04:15 pm
exel
Exelixis: The Cash-Generating Biotech That I Think Deserves a Closer Look in 2026 [Yahoo! Finance]
Low
Report
Exelixis: The Cash-Generating Biotech That I Think Deserves a Closer Look in 2026 [Yahoo! Finance]
2/16
11:17 am
exel
A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts [Yahoo! Finance]
Low
Report
A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts [Yahoo! Finance]
2/12
07:17 am
exel
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
2/12
07:14 am
exel
Exelixis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Exelixis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/11
11:48 am
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Royal Bank Of Canada from $45.00 to $46.00. They now have a "sector perform" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Royal Bank Of Canada from $45.00 to $46.00. They now have a "sector perform" rating on the stock.
2/11
10:24 am
exel
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Wells Fargo & Company from $30.00 to $35.00. They now have an "equal weight" rating on the stock.
Low
Report
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Wells Fargo & Company from $30.00 to $35.00. They now have an "equal weight" rating on the stock.
2/11
10:13 am
exel
Exelixis (NASDAQ:EXEL) was given a new $44.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Exelixis (NASDAQ:EXEL) was given a new $44.00 price target on by analysts at Stifel Nicolaus.